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Abstract A neuropathologic study of three cases of
prosaposin (pSap) deWciency (ages at death 27, 89 and
119 days), carried out in the standard autopsy tissues,
revealed a neurolysosomal pathology diVerent from
that in the non-neuronal cells. Non-neuronal storage
is represented by massive lysosomal accumulation of
glycosphingolipids (glucosyl-, galactosyl-, lactosyl-,
globotriaosylceramides, sulphatide, and ceramide).
The lysosomes in the central and peripheral neurons
were distended by pleomorphic non-lipid aggregates
lacking speciWc staining and autoXuorescence. Lipid
storage was borderline in case 1, and at a low level in
the other cases. Neurolysosomal storage was associ-
ated with massive ubiquitination, which was absent in
the non-neuronal cells and which did not display any
immunohistochemical aggresomal properties. Confocal
microscopy and cross-correlation function analyses
revealed a positive correlation between the ubiquitin
signal and the late endosomal/lysosomal markers. We
suppose that the neuropathology most probably reX-
ects excessive inXux of non-lipid material (either in
bulk or as individual molecules) into the neurolyso-
somes. The cortical neurons appeared to be uniquely
vulnerable to pSap deWciency. Whereas in case 1 they
populated the cortex, in cases 2 and 3 they had been
replaced by dense populations of both phagocytic micro-
glia and astrocytes. We suggest that this massive neuronal
loss reXects a cortical neuronal survival crisis precipi-
tated by the lack of pSap. The results of our study may
extend the knowledge of the neurotrophic function of
pSap, which should be considered essential for the
survival and maintenance of human cortical neurons.
Keywords Prosaposin deWciency · Neurolysosomal 
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Introduction
Prosaposin (pSap) deWciency is a rapidly progressive
fatal neurovisceral lysosomal storage disorder caused
by mutations in the PSAP gene which leads to the
blockage of pSap protein translation or to the prema-
ture (intranuclear) nonsense-mediated decay of pSap
mRNA [13, 25, 43, 54]. The proven genotypes result in
the absence of pSap and the products of pSap proteo-
lytic processing. These polypeptide products, called
saposins (Saps, sphingolipidhydrolase activating pro-
teins), are essential for activating a set of lysosomal
sphingolipid hydrolases [54]. In the absence of Saps,
the sphingolipid substrates remain undegraded. The
accumulated substrates, in visceral cell types, cause the
lysosomes to become distended, giving them a foamy
appearance and the process ultimately ends in organ
failure, similar to full blown classic lipid storage disor-
ders [3, 13, 25]. In this study, we show that in pSap deW-
ciency the neurolysosomes of both the peripheral and
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central neurons express a distinct pathology, which
may indicate a process resembling autophagocytosis.
Given the opportunity to compare the cortical struc-
ture at the earliest stage of the disease to that in the
more advanced stages, we were able to describe a
unique failure of cortical neurons to survive after
reaching the cerebral cortex. We would like to charac-
terize this destructive phenomenon, precipitated by the
absence of pSap, as a cortical neuronal survival crisis,
which seems to be a feature of human pSap deWciency.
This Wts well with the concept of pSap having funda-
mental neurotrophic functions [47].
Materials and methods
Formaldehyde Wxed paraYn embedded (FFPE) tissue
samples were available from three cases of veriWed
pSap deWciency. The life spans of the cases were:
27 days (case 1 [14]), 89 days (case 2 [25]) and 119 days
(case 3 [13]). In two of the three cases (27, 119 days) we
were kindly provided by colleagues from the pathology
departments unembedded routinely formaldehyde
Wxed samples of several cortical and subcortical brain
areas. The tissue samples available were as follows:
case 1 (27 days)–parts of the frontal and insular cortex,
striatum, pallidum, thalamus, and adjacent parts of the
white matter; case 2 (89 days)–several cortical samples,
thalamus, and basal ganglia; and case 3 (119 days)–
cerebral cortex from all lobes, cerebellum, pons,
medulla oblongata and spinal cord.
Histology, immunohistochemistry, electron 
microscopy and lipid biochemistry
The tissue sections (5 m) were dewaxed, hydrated and
hematoxylin-eosin stained. The primary antibodies and
their respective dilutions used for immunohistochemis-
try are listed in Table 1. The primary antibodies (incu-
bated overnight at 4°C) were detected with
Table 1 Dilutions and sources of antibodies
IH immunohistochemistry, IF immunoXuorescence
Antigen (Antibody clone) Source Dilution
IH IF
LAMP 1 (rabbit polyclonal) kindly provided by Dr.S.Carlsson 
(University of Umea, Sweden) 
1:200
LAMP 2 (rabbit polyclonal) kindly provided by Dr.S.Carlsson  1:200 1:100
Cathepsin D (rabbit polyclonal) DAKO, Copenhagen, Denmark 1:4000
Cathepsin D (MCA2068) Serotec, Raleigh, NC, USA 1:50
Ubiquitin (rabbit polyclonal) DAKO, Copenhagen, Denmark 1:1500 1:500
Ubiquitin (FPM1) Novocastra, Newcastle upon Tyne, 
United Kingdom
1:100 1:100
Poly ubiquitinylated proteins 
(FK1) [16]
Biomol, Plymouth Meeting, PA, USA  1:500
Mono- and poly ubiquitinylated 
proteins (FK2) [16]
Biomol, Plymouth Meeting, PA, USA  1:1000
LC3 (rabbit polyclonal) [27] MBL, Naka-ku Nagoya, Japan 1:500
Glial Wbrillary acidic protein - 
GFAP (6F2) 
DAKO, Copenhagen, Denmark 1:200
GFAP (rabbit polyclonal)  DAKO, Copenhagen, Denmark 1:500
CD68 (PGM1) DAKO, Copenhagen, Denmark 1:200 1:200
Neuron speciWc nuclear protein – 
NeuN (A60) 
Chemicon Int., Temecula, CA, USA  1:500
Prohibitin (II-14–10) Lab Vision, Westinghouse, CA, USA 1:500
60 kDa antigen of human 
mitochondria (113–1)
Biogenex, San Ramon, CA, USA 1:100 1:50
Subunit c of mitochondrial ATP 
synthase - SCMAS
kindly provided by prof. E.Kominami
(Juntendo University, Tokyo, Japan) 
1:200
p62 component of aggresome 
(guinea pig polyclonal) [67]
Progen, Heidelberg, Germany  1:4000
Activated caspase 3 
(rabbit monoclonal)
Epitomics, Burlingame, CA, USA  1:25
Protein disulWde isomerase
(PDI) (1D3)
Stressgen, Victoria, Canada  1:500Acta Neuropathol (2007) 113:163–175 165
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appropriate Envision TM  kits (DAKO, Copenhagen,
Denmark) or rabbit anti-guinea pig HRP labeled sec-
ondary antibody (DAKO).
In conjunction, various neurolysosomal storage dis-
orders (previously deWned biochemically at the Insti-
tute of Inherited Metabolic Disorders) were studied to
follow neuronal ubiquitination (for the list, see
Results). The FFPE tissue samples from various parts
of the brain were examined together with the samples
of storage aVected visceral organs.
The sections of the formaldehyde Wxed unembed-
ded samples (cases 1 and 2) were processed for elec-
tron microscopy after osmiWcation, using standard
dehydration in ethanol and embedding in an Aral-
dite–Epon mixture. The paraYn embedded samples
of the pons (case 3) were processed for electron
microscopy after deparaVination, hydration, and
osmiWcation.
The residual lipids extracted from the paraYn
embedded brain samples were analyzed using a proce-
dure recently described [13].
ImmunoXuorescence and laser scanning confocal 
microscopy
The FFPE paraYn embedded tissue sample from the
spinal cord (case 3) was chosen for immunoXuores-
cence multiple labeling colocalization analysis. The tis-
sue sections were treated as described above. The
primary antibodies and their dilutions used for immu-
noXuorescence labeling are listed in Table 1.
The combinations of the primary antibodies were
as follows: anti-LAMP2/anti-ubiquitin, anti-cathepsin
D/anti-ubiquitin, anti-LAMP2/anti-60 kDa antigen of
human mitochondria, anti-PDI/anti-ubiquitin, anti-
60 kDa antigen of human mitochondria/anti-ubiquitin.
The details of the tissue section processing and staining
protocol for both immunohistochemistry and immuno-
Xuorescence labeling are available from the authors
upon request.
Images (xy sampled at the maximum of z Xuores-
cence intensity) were acquired using a Nikon Eclipse
E800 microscope equipped with a C1 confocal head
and 488, 543 and 633 nm laser lines and appropriate
515 § 15 nm, 590 § 15 nm and 650LP band pass
Wlters. The sampling density was corrected to con-
form to the Nyquist criterion according to the objec-
tive lens used (Nikon Plan Apo 60 £ 1.4 N.A.). The
microscope settings including laser intensity, pinhole
size, pixel dwell times; photomultiplier gains were
kept constant for all image acquisitions and the
images were checked for the presence of spectral
cross-talk.
Point spread functions (PSF) at appropriate excitation/
detection wavelengths were measured using PS-Speck
Microscope Point Source Kit (Invitrogen- Molecular
Probes, Carlsbad, CA).
The cerebral cortex sample from (case 2, day 89)
was double-labeled with mouse monoclonal anti-CD
68 and rabbit polyclonal anti-GFAP antibodies. Sec-
ondary detections were performed using donkey anti-
mouse IgG Alexa Fluor 555 and goat anti-rabbit IgG
Alexa Fluor 488 antibodies (Invitrogen- Molecular
Probes, Carlsbad, CA) diluted 1:500.
Image restoration, processing and cross-correlation 
function (CCF) analysis
Between 25 and 30 images of neurons of the spinal
cord anterior columns were acquired and further pro-
cessed for each of the double-labeling experiments.
The images were restored based on deconvolution
using an appropriately measured PSF with a classical
maximum likelihood estimate algorithm (Huygens
Professional software, SVI, Hilversum, Netherlands).
Only pixels included in the neurons were further evalu-
ated without any additional thresholding or pixel inten-
sity manipulation. Cross-correlation function analysis
[65] was performed using a Tcl/Tk script employing the
Huygens Scripting modality in Huygens Professional
software. Single pixel shifts with parallel Pearson’s
coeYcient calculations were applied to the red channel
of the images with respect to the green channel to the
extent of ¡4 to +4 m (only values ¡3 to +3 m are
shown, Fig. 5). The appropriate pixel shifted Pearson’s
coeYcient values were calculated for each individual
evaluated shifted image. The median values and 5/95
percentile values and Wrst and third quartile values of
Pearson’s coeYcient were plotted on the y axis for each
single pixel shifted position (x axis) to get the Wnal
cross-correlation curves and to document the distribu-
tion of the values.
The Pearson’s coeYcient values range from ¡1 to
+1. Positive Pearson’s coeYcient values at x =0  d e m -
onstrate signiWcant overlap (colocalization) of the
signals, negative values demonstrate repulsion (anti-
colocalization) of the signals, and values around zero
demonstrate a random distribution of signals. The
details of the Tcl/Tk script used to calculate CCF is
available from the authors upon request. All the image
manipulations and Wgure preparations were performed
using Huygens Professional or ImageJ (NIH, http://
www.rsb.info.nih.gov/ij/) software.
In order to avoid any ambiguity, the use of neurolys-
osomal in this paper refers to the lysosomal compart-
ment of neurons.166 Acta Neuropathol (2007) 113:163–175
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Results
General neuropathology
The general neuropathologic Wndings in all the three
cases have already been published [13, 14, 25]. How-
ever, to brieXy summarize, the neuronal perikarya
were variably distended by Wne eosinophilic non-auto-
Xuorescent granules (Figs. 1a inset, 2a). Neuronal stor-
age was present in all the regions available for
examination: brain cortex (see below), basal ganglia,
thalamus, pons, medulla oblongata, spinal cord, and
cerebellum. The only exception was the subventricular
zone (cases 1 and 2) which was cellular and devoid of
histological and immunohistochemical abnormalities.
There was a marked diVerence between the brain corti-
cal pathology in case 1 as compared to cases 2 and 3
(see below). Storage was manifested in the peripheral
nervous system in all samples available (gut, lung, liver,
kidney, and urinary bladder).
Fig. 1 Cortex in case 1 
(day 27) in pSAP deWciency. 
a Numerous cortical neurons 
with a rather normal architec-
ture. Discrete neuronal stor-
age accented in basal layers 
(inset); H&E. b Strong neuro-
nal perikaryal staining for 
cathepsin D. c Paucity of mi-
croglial phagocytes demon-
strated by CD 68 antibody 
(clone PGM1), and d of astro-
glia stained with GFAP anti-
body. a–d correspond to the 
identical cortical area. Scale 
bar 200 m a–d. Scale bar in 
inset in (a) 100 m
Fig. 2 Neuronal cytology and 
immunodetection of lyso-
somal markers in pSAP deW-
ciency. a Case 1 (day 27): a 
subcortical storage neuron 
with the perikaryal region dis-
tended by Wne granules; H&E. 
b Case 3 (day 119): storage in 
spinal motor neuron with a 
granulovacuolar appearance 
of the perikaryon. c Case 1 
(day 27): strong staining of the 
perikaryal granules for 
cathepsin D and for LAMP 2 
d. Scale bar 50 mActa Neuropathol (2007) 113:163–175 167
123
The following data represent novel and previously
unreported features of the neurolysosomal storage
process in pSap deWciency.
Study on the nature of neurolysosomal processes
Cytology, electron microscopy and lipid biochemistry
Contrary to the foamy appearance of the storage cells
in the visceral region, the neuronal perikarya were dis-
tended even ballooned by a uniform population of Wne
eosinophilic granules. In case 3, their appearance
changed to granulovacuolar (Fig. 2b). The granules
were not autoXuorescent and did not exhibit any dis-
tinct staining in routine histological stainings. Lipid his-
tochemistry showed an absence of birefringence and
no signiWcant detectable amounts of glycolipids and
sphingolipids [14].
In contrast to the neurons the astrocytes displayed
signiWcantly milder storage changes [13, 25]. Regarding
the oligodendroglia, the lysosomal storage has never
been demonstrated [13,  17]. Changes of microglial
phagocytes are discussed below.
Electron microscopy (cases 1 and 2) showed vacu-
oles approximately 0.5 m in diameter containing
numerous dense granules of various densities, 45–
230 nm in diameter, sometimes with amorphous or
coarse membranous substructure, occasionally resem-
bling degraded mitochondria (Fig. 3). Identical struc-
tures were observed in the dystrophic axons. Other
organelles (RER, Golgi aparatus), while reduced in
number, were without substantial alteration. Electron
microscopy of dewaxed pontine samples (case 3)
showed similar structures. The only diVerence was an
increase of electron lucent space in the storage com-
partment leading to granulovacuolar neuronal cytol-
ogy and an increase in the size of individual storage
lysosomes, up to 1 m in diameter on average. The
ultrastructure diVered from the ultrastructure of the
lysosomes in the visceral storage cells [25] and from
the lysosomes of the other known neurolysosomal
storage disorders featured by membranous lipid
deposits.
Biochemical analysis of residual lipids in FFPE sam-
ples from the pons (case 3, day 119) which were rich in
ballooned granulovacuolar neurons, revealed a three-
fold to sixfold elevation of gangliosides (GM1, GM2,
GM3 types), lactosylceramide and globotriaosylcera-
mide as compared to the controls (data not shown). At
this point we must note some limitations of the analysis
caused by previous dehydrations, as well as the poten-
tial contribution (although minor) to the overall lipid
content of non-neuronal storage elements present in
the tissue.
Fig. 3 Ultrastructure of a 
subcortical neuron in case 1 
(day 27) of prosaposin deW-
ciency. a A dense population 
of lysosomes containing pleio-
morphic condensed deposits. 
b–e Some of the deposits 
resemble degenerated mito-
chondria (arrows c–e), for 
comparison refer to intact 
mitochondrion (b, arrow). 
MagniWcation £28,000168 Acta Neuropathol (2007) 113:163–175
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Immunohistochemistry, immunoXuorescence, laser 
scanning confocal microscopy (LSCM) and cross-cor-
relation function (CCF) analysis
In all the three cases the neuronal perikaryal storage
granules displayed a uniform lysosomal immunophe-
notype, featured by strong staining for cathepsin D
(luminal marker) and for the late endosomal/lysosomal
membrane markers LAMP1, 2 (Figs. 1b, 2c, d). In the
majority of storage neurons the perikaryal granules
displayed variable positivity for the subunit c of mito-
chondrial ATP synthase (SCMAS) with the respective
antibody (data not shown).
A peculiar feature of the immunophenotype was the
nearly uniform, strong, granular immunostaining of
ubiquitin (Fig. 4a–c), present in all analyzed samples
(cortical, subcortical and extra cerebral). The cortical
neurons in case 1 were ubiquitinated almost without
any substantial diVerence between the individual lay-
ers. Axonal spheroids were ubiquitinated as well. The
neurons of the peripheral nervous system (gut, lung,
liver, kidney, and urinary bladder) displayed an identi-
cal lysosomal immunophenotype, including the high
extent of ubiquitination (Fig. 4d). The cellular pattern
of ubiquitination, seen in bright-Weld microscopy, was
suggestive of its association with storage lysosomes (for
details, see below).
To evaluate the proportion of ubiquitin protein con-
jugates (mono- and polyubiquitinated) in the overall
ubiquitin signal, the antibodies (clone FK1 and FK2,
Table 1) against these types of epitopes [16] were used.
We were able to detect signiWcant amounts of mono-
and polyubiquitinated moieties (FK2 antibody, data
not shown) with the same staining patterns as the
above-described ubiquitin staining. Unfortunately, the
FK1 antibody (polyubiquitinated protein conjugates)
did not provide reliable staining in the control samples
(Mallory bodies rich liver biopsy) and as such was not
included in the study. The cortical neurons in age-
matched controls were immunonegative for ubiquitin.
The immunophenotype of storage lysosomes in all the
aVected non-neuronal cells, from the brain (astrocytes,
microglial phagocytes) and the visceral region was
identical to the neurolysosomes, except for the absence
of any detectable ubiquitination (Fig. 4e).
The immunohistochemical detection of cytoplasmic
aggresomal sequestered proteins using p62 antibody
did not show any positivity in any of the evaluated cor-
tical and subcortical brain samples of all the three cases
(data not shown).
In contrast to pSap deWciency, neurolysosomal ubiq-
uitination was undetectable in the following neurolysos-
omal storage disorders: Niemann–Pick disease type C1,
type A (Fig. 4f), infantile sialic storage disorder, muco-
lipidosis type I, aspartylglucosaminuria, alpha-mannosi-
dosis, polysulphatase deWciency, and glycogen storage
disease type II. Only the axonal spheroids and the
neuronal tangles, particularly numerous in protracted
Fig. 4 Immunodetection of ubiquitin in prosaposin deWciency
(except for panel f). a Strong granular staining in perikarya of
subcortical storage neurons in case 1 (day 27), and b case 2
(day 89). c Uniform strong ubiquitination in pontine storage neu-
rons in case 3 (day 119), and d in peripheral neurons of the kidney
hilus in the same case. e Absence of detectable ubiquitination in
the storage cells in the liver in pSap deWciency (case 2). f Absence
of ubiquitination in storage neurons in Niemann–Pick-disease
type A. Inset shows intense ubiquitination of the small dystrophic
axon close to another negative neuronal perikaryon. Scale bar
25 m (a,b) and 100 m (c–f)Acta Neuropathol (2007) 113:163–175 169
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neuronopathic Niemann–Pick type C cases, displayed
strong ubiquitination. In neuronal ceroid lipofuscinoses,
types 2, 3, 4 and 8, the main population of storage gran-
ules was devoid of ubiquitination. The only exception
was strong ubiquitination seen in a small population of
transformed storage material present as globules or
spheroids in the neuronal perikarya [12]. Moderate
ubiquitination of storage neurons has been seen in the
group of mucopolysaccharidoses (types I–III). Extra
cerebral non-neuronal storage cells in all the above-
mentioned disorders lacked any detectable ubiquitination.
We could not conWrm improved ubiquitin immunostaining
with the recommended pretreatment [34].
Multiple indirect immunoXuorescence labeling
experiments were performed on sections of the spinal
cord (case 3) in order to evaluate the relationship
between the detectable ubiquitin signals and the poten-
tially involved, cellular compartments. Prior to the
evaluation of the signals in confocal images, we per-
formed image restoration based on deconvolution
using the microscope’s measured PSF, a method
known to increase the eVective image resolution [35,
57, 64]. The characteristics of the signals in the evalu-
ated images allowed us to apply the cross-correlation
function (CCF) estimation [65] for the analysis of their
spatial (colocalization) relationship. The CCF method
of colocalization evaluation of complex staining pat-
terns is advantageous because it does not require
image segmentation and can discriminate positive, neg-
ative and non-correlating signals.
In general, the signals obtained by immunoXuores-
cence labeling followed the patterns observed by
immunohistochemical staining. The intensity of the
ubiquitin signal was inversely correlated to the endo-
plasmic reticulum (ER) and mitochondrial signals
among the evaluated neurons. This resulted in a popu-
lation of neurons strongly positive for ubiquitin and
almost negative for ER and mitochondrial signals. This
feature could be documented by the distribution of
Pearson’s coeYcient values in the CCF plots (Fig. 5c,
d). While this loss of epitope detectability in the pres-
ence of strong ubiquitin positivity was clear for the ER
and mitochondrial epitopes, a similar phenomenon was
not observed for the two late endosomal/lysosomal
markers (LAMP2, CatD).
In addition, the double labeling of the mitochondrial
epitopes and of the late endosomal/lysosomal mem-
brane epitope (LAMP2) in search for lysosomes with
entrapped mitochondria or for mitochondrial remnants
did not provide clear evidence of such events. This was,
most probably, due to the combination of diVraction
limited resolution of the microscope and/or advanced
degradation of the mitochondrial epitopes.
Figure 5 shows images of the selected neurons with
the corresponding CCFs and their distribution for the
above-mentioned immunoXuorescence labeling. From
the Wve evaluated labeling combinations, only the sig-
nals of ubiquitin and LAMP 2/cathepsin D showed a
non-random distribution (colocalization) according to
the CCF in the population of evaluated neurons
(Fig. 5a, b). The full-width of the half maximum
(FWHM) of the CCF curves should correspond to the
diameter of the evaluated objects [65]. This criterion
stands for the median value of both the CCF curves
representing the ubiquitin/LAMP2-CatD signals and
corresponds to the diameter values obtained by elec-
tron microscopy. The characteristics of ubiquitin/
LAMP2 and ubiquitin/cathepsin D CCF curves
(FWHM or maximum Pearson’s coeYcient values) did
not allow unambiguous discrimination between the
prevalence of the two phenomena i.e. ubiquitination of
the late endosomal/lysosomal membranes or ubiquiti-
nation of the late endosomal/lysosomal contents.
Despite this ambiguity, which is most likely caused by
the resolution limit of the microscope, we were able to
demonstrate the colocalization of the ubiquitin signal
with the late endosomal/lysosomal cellular compart-
ment in pSap deWcient neurons. Analysis of the other
staining combinations (anti-ubiquitin/anti-PDI, anti-
ubiquitin/anti-60 kDa antigen of human mitochondria
and anti-60 kDa antigen of human mitochondria/anti-
LAMP2) yielded a wide distribution of values, ranging
from random distributions to mild exclusion of the sig-
nals (negative values of the Pearson’s coeYcient)
(Fig. 5c–e). CCF found that for the anti-60 kDa antigen
of human mitochondria/anti-LAMP2 (mitochondrial/
lysosomal), staining could be regarded, in this case, as a
positive control for a random/exclusion relationship of
the signals.
Limited survival potential of cortical neurons
A comparison of brain cortical neuropathology showed
pronounced diVerences between case 1 and cases 2 and
3. The histology in case 1 revealed a dense population
of cortical neurons without substantial numerical and
structural deviation from age-matched controls. The
cortical neurons were moderately aVected by storage,
with a gradual increase toward the deeper layers
(Fig. 1a). The neuronal nuclei were mostly vesicular
with well-discernible nucleoli. The process culminated
in the neurons of the subcortical regions (thalamus and
basal ganglia). The degree of astrocytosis and the num-
ber of microglial phagocytes were proportional to the
degree of neuronal storage, i.e. it was minimal in the
cortex (Fig. 1c, d). In cases 2 and 3 the cortical areas170 Acta Neuropathol (2007) 113:163–175
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Fig. 5 Laser scanning confocal microscopy. Figure shows iso-
lated gray scale single channel, and merged RGB images of the
double-labeled neurons for appropriate indirect immunoXuores-
cence labels (used antibodies given in panels a–e). On the right
are the corresponding CCF curves: Full line median values, dotted
lines 5/95 percentile values, dashed lines 1st and 3rd quartile (for
details on graph construction see Methods). CCF values were
determined only for the pixels located inside the neurons, the sur-
rounding tissue was excluded from the CCF calculations. Positive
Pearson’s coeYcient values demonstrate signiWcant overlap (col-
ocalization) of the signals, negative values demonstrate repulsion
(anti-colocalization) of the signals, and values around zero dem-
onstrate random distribution of the signals. For CCF calculation
refer to Materials and methods. Scale bar (10 m)Acta Neuropathol (2007) 113:163–175 171
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displayed a profound depletion of the neurons [13, 25]
and the residual neurons were identiWed as Wnely gran-
ulated single cells or small groups of cells that were
detectable by using the NeuN antibody. Instead of the
normal neuronal architecture there was a dense cellu-
lar population composed of equal proportions of large,
coarsely vacuolated, CD 68 positive phagocytic micro-
glia and hyperplastic, GFAP positive astrocytes
(Fig. 6). In the rest of the central nervous system, the
neurons were not substantially reduced in amount. No
signs of caspase 3 activation or other cytological fea-
tures of apoptosis were present either in the cortical or
the subcortical neurons in case 1 or in the neurons in
cases 2 and 3 (data not shown).
Discussion
In all the three cases there was a complete absence of
pSap protein caused either by the nonsense-mediated
decay of the gene transcript [25] or by the failure of the
mRNA translation [13, 54]. The discussion is focused
on the nature of neurolysosomal storage and the
remarkable sensitivity of the cortical neurons to pSap
deWciency.
Nature of the neurolysosomal process
Whereas lysosomes in non-neuronal cells were dis-
tended by a massive accumulation of a set of sphingoli-
pids due to multiple sphingolipid hydrolase
insuYciency, due to pSap deWciency, leading to the
foamy appearance of the aVected cells, the neurons
expressed an appreciably diVerent pathology. The neu-
ronal pathology featured Wnely granular lysosomes
containing condensed pleiomorphic inclusions. Besides
the standard membrane (LAMP 1 and LAMP 2) and
luminal (cathepsin D) markers, their distinct feature
was an association with strong ubiquitination including
a signiWcant proportion of ubiquitin protein conjugates
detected by speciWc antibodies. They were devoid of
ceroidlipofuscin and the lipid storage was borderline or
of a low degree. We consider it important that ubiquiti-
nation has been proved to be absent in non-neuronal
storage cells and even in numerous microglial phago-
cytes. It was also absent in the bulk of other neurolys-
osomal storage disorders featured by storage of
deWned lipid or glycoconjugate substrates due to deW-
cient enzyme catalytic activity or due to altered lipid
traYcking (see also [68]). Thus, in contrast to the non-
neuronal cells, the absence of pSap leads to a diVerent
pathology in the neurolysosomes.
It should be compared to processes featured by the
lysosomally associated ubiquitination. Ubiquitination
associated with neurolysosomes has been described in
the granulovacuolar lesions seen in Alzheimer’s dis-
ease and in scrapie infected mice, both appear to be
autophagic vacuoles [39]. The ultrastructure of neuro-
lysosomes in neuronal perikarya (Fig. 3) and axons in
our cases of pSap deWciency resembled ultrastructural
changes in the neuroaxonal dystrophy classiWed as a
macroautophagy process [46] that also featured a high
degree of ubiquitination [11, 42] combined with lyso-
somal enzyme activities [63].
Fig. 6 Neuronal cortical crisis 
in prosaposin deWciency. Case 
2 (day 89). a Low power mag-
niWcation (H&E) showing cel-
lular cortex with well 
preserved shape and well 
delineated from the white 
matter (inset). b Very few 
residual neurons stained with 
NeuN antibody. c Dense cel-
lularity of cerebral cortex in 
case 2 (day 89) formed by two 
distinct cell populations (CD 
68 positive microglial phago-
cytes and GFAP positive as-
trocytes), LSCM acquired 
image. Note the intimate con-
tact of the two cell types. Scale 
bar 500 m a, b and 50 m c. 
Compare with Fig. 1172 Acta Neuropathol (2007) 113:163–175
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In the cases of pSap deWciency we were able to doc-
ument a positive correlation (colocalization) to ubiqui-
tination and late endosomal/lysosomal markers as well
as signs attributable to mitochondrial degradation
(SCMAS detectability).
Ubiquitination has also been described as a part of
the protein conjugation system of autophagosomal
compartment [18,  38,  58,  59], a process dominated,
however, by the homologs of yeast Atg ubiquitin-like
proteins including mammalian LC3 protein [27,  28].
Unfortunately, the antibody against the LC3 autophag-
osomal membrane component provided ambiguous
results in our FFPE tissues, partly due to the lack of
appropriate reference samples; therefore we decided
not to include these results. Ubiquitination of lyso-
somal contents has been repeatedly described [10, 36,
37, 41, 58] and explained by lysosomal sequestration of
ubiquitin-tagged proteins.
We thus propose the existence of a similar mecha-
nism in pSap deWciency, i.e. excessive lysosomal
sequestration of the ubiquitin-tagged proteins released
most probably from damaged neuronal membranes or
resulting from impaired downstream pSap signaling [2,
23]. The previously demonstrated relationship of the
ubiquitin/proteasome pathway and cytoplasmic vacu-
oles with non-lysosomal characteristics [61] does not
correspond with our Wndings in pSap deWciency. The
absence of immunodetectable p62 does not support the
aggresomal-based ubiquitination [67] in pSap deW-
ciency neuropathology, nevertheless, ubiquitination
has been suggested to trigger an autophagocytosis pro-
cess under certain conditions [30]. In summary, our
Wndings can be interpreted as an excessive inXux of
ubiquitinated biological material (either in bulk or as
individual molecules) into the neurolysosomes. It rep-
resents features compatible with the process of auto-
phagy, encompassing a range of both bulk (macro and
micro types) and of its molecular variants, [8, 49, 53]
which are diYcult to distinguish in routinely processed
FFPE samples. It is worth mentioning that the absence
of neurotrophic factors was found to activate auto-
phagocytosis, which may culminate in a speciWc type of
programmed cell death (PCD II) [4, 59] or persist as an
ongoing process [40]. This supports our hypothesis that
the speciWc neurolysosomal pathology in human pSap
deWciency may be closely related to the absence of
pSap´s trophic function.
Selective vulnerability of the cortical neurons–the 
cortical neuronal survival crisis
The vulnerability of the cortical neurons to cell death
in pSap deWciency is immense. The Wndings in the three
presented cases suggest a critical inability of nearly the
whole cortical neuronal population to survive after a
certain postnatal time point. The subependymal germi-
nal zone as well as the neuronal migration does not
seem to be aVected. This massive, stage dependant
neuronal loss, most probably triggered by pSap
absence, occurs within a time period of 60–80 days.
With respect to the extent and relative abruptness of
this phenomenon we would like to designate it as a cor-
tical neuronal survival crisis. A similar phenomenon
has never been described in any of the known neuro-
lysosomal storage disorders, with the exception of
infantile NCL1 and the recently described congenital
NCL [60]. In infantile NCL1, the profound neuronal
cortical depopulation develops over several years [56],
strongly contrasting with the early cortical neuronal
survival crisis in pSap deWciency. The congenital NCL,
caused by profound cathepsin D deWciency, is featured
by extensive prenatal neuronal loss.
Unfortunately, brains from other cases of pSap deW-
ciency [19, 66] were not available for study. The loss of
neuronal survival capacity as described has been
repeatedly reported as a consequence of neurotrophic
factor deprivation leading to programmed cell death,
mostly from the caspase independent (non-apoptopic)
type [1, 9, 26, 29, 52]. The absence of detectable acti-
vated caspase 3 in our cases is in accord with it. It
should be stressed that an amino acid sequence has
been recognized in pSap [33, 48, 51] as being responsi-
ble for the neurotrophic activities in a variety of neural
cells in vitro and in vivo, including diVerentiation, cell
death prevention, regeneration [5, 24, 32, 33, 47, 55],
and stimulation of myelin synthesis [7,  21,  22]. Cell
death prevention by pSap has also been described in
non-neuronal U937 monocytic cells [7, 44]. It has been
postulated that unprocessed pSap, localized to both
fetal and adult human neurons [15, 31], exerts its neu-
rotrophic eVect partly through a putative Go protein
coupled receptor [20] and MAP kinase [6], and partly
due to its unique aYnity for glycosphingolipids, partic-
ularly gangliosides [45].
The above-mentioned data support the concept of
pSap as having a crucial role in the survival of human
cortical neurons and indicate that its absence may be
critical for their survival in early postnatal life.
In this context it is worth noting that in the mouse
pSap KO model [17, 50], the neurolysosomal storage
starts around day 10 and 30 in spinal and cerebral neu-
rons, respectively, and progresses rapidly to full blown
glycolipid storage. As in human cases, storage is
accompanied, by a high degree of neuronal ubiquitina-
tion. The neurological symptoms start on day 20. The
animals do not survive beyond day 40. No signs ofActa Neuropathol (2007) 113:163–175 173
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neuronal cortical depopulation have been described.
These Wndings might point to the absence of a signiW-
cant trophic eVect of pSap on normal mouse neurons
despite the fact that there is a strong postnatal increase
in its mRNA [62].
Conclusions and perspectives
Our results indicate that pSap deWciency in humans has
diVerent consequences with respect to the cell types
aVected. In non-neuronal cells, the disorder does not
lead to any demonstrable trophic defect and is domi-
nated by the biochemical sequels linked to the absence
of Saps i.e. inactivation of multiple sphingolipid hydro-
lases. The resulting storage of undigested lipids mark-
edly distends the lysosomal compartment. However, in
the peripheral and central neurons, the consequences
of pSap deWciency seem to be determined by the
unique sensitivity of the neurons to the lack of a tro-
phic eVect of secreted unprocessed pSap. We speculate
that the initial phase of the neurolysosomal process (in
both brain and peripheral neurons) strongly resembles
autophagocytosis, while lipid storage plays only a
minor role. In the cortical neurons the process seems to
be terminated after several weeks of life by massive
cell death, which by exclusion corresponds most proba-
bly to the programmed cell death type II, followed by
removal by microglial phagocytes. It appears likely
that pSap is one of the trophic factors essential for sur-
vival, diVerentiation and maintenance of human neu-
rons particularly in the early phases of brain
development.
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